Mutual Termination AgreementMutual Termination Agreement • March 14th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • New York
This Mutual Termination Agreement, dated March 11, 2016 (the “Agreement”), is by and among Strand Life Sciences Private Limited (“Strand LS”), Strand Genomics, Inc. (“SGI” and with Strand LS, “Strand”), and Venaxis, Inc. (“Venaxis”). Reference is made to the Master Agreement, dated January 26, 2016 (the “Master Agreement”), by and among Strand and Venaxis, and in particular Section 7.1(a) and Section 7.2 of the Master Agreement. All defined terms used in this Agreement without definition have the meanings set forth in the Master Agreement.
